Johnson & Johnson (BCBA:JNJ)

Market Cap	552.39T
Revenue (ttm)	107.61T
Net Income (ttm)	26.91T
Shares Out	n/a
EPS (ttm)	11,083.28
PE Ratio	20.53
Forward PE	16.16
Dividend	226.09 (1.48%)
Ex-Dividend Date	May 27, 2025

Volume	7,596
Average Volume	12,350
Open	15,450
Previous Close	15,400
Day's Range	15,150 - 15,450
52-Week Range	10,425 - 15,550
Beta	0.40
RSI	68.53
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD